# DigeHealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/digehealth

- Industry: Healthcare IT
- Headquarters: Epalinges, Switzerland
- Website: www.digehealth.ch/
- Total disclosed funding: $1.6M
- Latest round: Seed (Dec 9, 2025)
- Investors on record: 1

## About

Based in Switzerland, DigeHealth AG develops advanced gastrointestinal monitoring solutions aimed at improving health outcomes through innovative wearable technology.DigeHealth AG, founded in 2023 and headquartered in Epalinges, Switzerland, focuses on gastrointestinal health monitoring. The company raised CHF 1.25 million in Seed funding from Venture Kick in December 2025, marking its first significant funding round. The founder's background is not specified.DigeHealth specializes in advanced gastrointestinal monitoring solutions that focus on continuous, non-invasive bowel monitoring. The company's core product is a wearable device that records bowel sounds along with vital metrics such as heart rate, heart rate variability, and activity levels. This technology employs AI-powered algorithms to analyze physiological data in conjunction with contextual information, thereby providing insights into various bowel conditions, dietary intolerances, and responses to environmental factors. The product is designed for a diverse client base that includes individuals suffering from functional gastrointestinal disorders, post-operative recovery needs, and specific nutritional requirements. DigeHealth's offerings cater predominantly to markets across Europe and North America, where there is a significant prevalence of bowel disorders, affecting approximately one-third of the global population.DigeHealth's revenue model is structured around direct sales of its wearable monitoring devices and associated software analytics services. Transactions typically occur through partnerships with healthcare providers, researchers, and academic institutions interested in gastrointestinal health. The company also engages with individual consumers through direct-to-consumer sales channels. Revenue generation may include subscription-based services for ongoing data access and analytics, enhancing user experience and engagement. Pricing structures for their flagship products and services are determined based on the value provided through real-time health monitoring and data analytics, allowing for tailored solutions that meet the specific needs of their diverse clientele.In December 2025, DigeHealth AG raised CHF 1.25 million in Seed funding from new investor Venture Kick. The company will use the funding to develop next-generation gastrointestinal monitoring technology, which includes upcoming product enhancements targeting improved health insights. Additionally, DigeHealth plans to expand its market presence in Europe and North America by the end of 2026.

## Funding rounds

- Seed, Dec 9, 2025, $1.6M — Venture Kick

## Investors

- Venture Kick (https://capitalatlas.ai/funds/venture-kick) — Seed